Mesothelioma remains difficult to detect at an early stage. Doctors therefore explore blood and fluid-based biomarkers. Three proteins receive special attention. These are mesothelin, fibulin-3 and osteopontin. Each offers useful information for diagnosis and monitoring. Mesothelin appears in high amounts on mesothelioma cell surfaces. The body releases a soluble form into the blood. This form […]
Tag: Mesothelioma
Liquid biopsy analyzes body fluids for cancer-related markers. Researchers apply this method to track mesothelioma progression. The approach avoids repeated invasive tissue biopsies. Therefore, it offers a safer option for patients. Mesothelioma often develops in the lining of the lungs or abdomen. Traditional monitoring relies on imaging and tissue samples. However, these methods have limitations. […]
Mesothelioma Pathophysiology: How Asbestos Fibers Damage Cells Mesothelioma develops when asbestos fibers enter the body and disrupt normal cell function. These fibers are sharp, durable, and resistant to breakdown. Once inhaled or ingested, they lodge in the lining of the lungs, abdomen, or heart. Fiber Inhalation and Retention Asbestos fibers bypass natural defense mechanisms in […]
Researchers conduct a spatio-temporal analysis of mesothelioma incidence. They also examine asbestos exposure patterns. The study relies on statistical modeling of incidence rates. Cancer registry records and occupational history data provide the main sources. Scientists map cases across different regions and time periods. They identify clusters and changing trends. In addition, they link these patterns […]
Pathologists face challenges when distinguishing peritoneal mesothelioma from peritoneal carcinomatosis. Both conditions can appear similar under the microscope. Accurate diagnosis remains essential for proper treatment planning. Immunohistochemical and molecular biomarker analysis helps resolve this difficulty. Immunohistochemistry forms the first line of investigation. Pathologists apply a panel of antibodies to tissue samples. Mesothelial markers such as […]
Analysis of Immune Checkpoint Inhibitor Efficacy in Mesothelioma Immune checkpoint inhibitors have changed treatment approaches for several cancers. Researchers now examine their effectiveness in mesothelioma. Studies stratify results by PD-L1 expression and histological subtype. This analysis helps identify which patients benefit most. PD-L1 expression serves as a key biomarker. Higher PD-L1 levels often correlate with […]